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Abstract
Background: Neonatal systemic vasculitis syndromes have been reported in infants born to mothers with systemic
lupus erythematosus, Sjögren’s syndrome, Behҫet’s disease, cutaneous polyarteritis nodosa and anti-neutrophil
cytoplasmic antibody-associated vasculitides. Here we report a novel association of a case of new-onset maternal
seronegative inflammatory arthritis associated with a transient systemic vasculitis in a neonate.
Case presentation: In the first 24 h of life, a preterm Caucasian baby boy was noted to have blue discoloration to
all four extremities. Despite antibiotics, fresh frozen plasma and anticoagulation, the discoloration remained,
particularly in the left index finger. This was associated with fever and a maximum C-reactive protein (CRP) of 148
mg/L. Intravenous immunoglobulin (IVIG) was given with short-term improvement. Initial echocardiogram showed
enlarged coronary arteries with normalization on repeat 1 week later. Clinical signs and symptoms responded to
high dose oral steroid administration. MRI angiography (MRA) of the body and heart showed tortuosity of arteries
in the upper and lower extremities with gadolinium uptake, suggestive of vasculitis. Autoantibody profile negative.
Genetic panel for hereditary autoinflammatory diseases was negative as was whole exome sequencing performed
on the trio. The baby was weaned off steroids by 5 months of age. A small distal autoamputation of the left index
finger occurred.
He was born to a 28-year-old woman who developed new onset severe symmetrical polyarthritis at 8 weeks
gestation. This was presumed a reactive arthritis secondary to a dental infection. Infectious work up and
autoantibodies were negative. She was treated with high dose prednisone for the remainder of her pregnancy.
The mother was weaned off prednisone, treated with hydroxychloroquine for 8 months post-partum and remains
in remission. A repeat MRA done at 1 year old showed mild residual tortuosities of the arteries in the forearms. The
remainder of the medium and large vessels were within normal limits with no gadolinium enhancement to suggest
active disease. The child is now 4 years old with normal growth and development.
Conclusion: This is a unique case of new-onset seronegative presumed reactive arthritis in a mother with the rare
development of a successfully treated medium vessel vasculitis in an infant.
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Background
During pregnancy many changes occur in the immune
system to allow tolerance to the fetus. A level of immunosuppression is required as the fetus expresses paternally inherited alloantigens which requires the mother
to create a sense of tolerance. One mechanism of tolerance suggested is the switch from Th1 cytokine profile
to the Th2 profile [1]. Certain Th1 predominant autoimmune diseases such as rheumatoid arthritis tend to
show improvement during pregnancy, while Th2 predominant diseases such as systemic lupus erythematosus
tend to flare [2]. Neonatal vasculitis in infants born to
mothers with systemic lupus erythematosus, Sjögren’s
syndrome and systemic vasculitides have been described.
Here we report the first case, to our knowledge, of a
new onset of seronegative inflammatory arthritis in a
primiparous mother associated with the development of
an effectively treated systemic vasculitis syndrome in the
neonate.
Clinical case

A Caucasian male infant was born at 33 weeks and 4
days gestation via caesarian section, due to fetal tachycardia, following spontaneous premature rupture of
membranes. APGAR scores were 9 at 1 min and 9 at 5
min. Birth weight was 2920 g (90th percentile), head circumference 34.5 cm (>97th percentile), length of 44 cm
(40th percentile). There were no dysmorphic features.
Within the first 24 h of life, blue discoloration was noted
to the distal left second finger which progressed to multiple fingers and toes in all four limbs. The infant was
transferred to a tertiary care neonatal intensive care unit
for evaluation.
The mother, a 28-year-old Caucasian woman, developed new onset symmetrical polyarthritis during her
first trimester of pregnancy. Past history was significant
for a previous miscarriage at 5 weeks gestation and a
cholecystectomy. Family history was negative. There was
no smoking, alcohol or drug use during pregnancy. Prenatal screening showed rubella titre indeterminant (7.4
IU/ml) as well as hepatitis B, human immunodeficiency
virus, syphilis negative. Parvovirus B19 immunoglobulin
G (IgG) reactive, cytomegalovirus IgG non-reactive,
toxoplasmosis IgG negative.
At 6 weeks’ gestation, the mother underwent dental
work complicated by an oral abscess requiring 7 days of
amoxicillin. Two days after initiation of amoxicillin, she
developed severe myalgias, episodes of nausea, vomiting
and diarrhea which resolved in a few days. There was no
associated fever, rash, or urinary symptoms. At 8 weeks
gestation she presented with severe polyarthritis affecting large and small joints with significant functional impairment. She was prescribed oral prednisone (15 mg
oral daily) at 10 weeks’ gestation for a presumed reactive
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arthritis. Blood work prior to treatment showed elevated
inflammatory markers including C-reactive protein
(CRP) of 210 mg/L (normal < 3 mg/L) and erythrocyte
sedimentation rate (ESR) of 60 mm/hr. (normal 0-20
mm/hr). She was steroid dependent for the remainder of
the pregnancy requiring high dose prednisone (25 mg
orally twice daily) with return of symptoms below this
dose.
Additional infectious work up was complete including
Epstein Barr virus and Lyme serology which were negative. Prior to treatment her anti-nuclear antibody
(ANA), extractable nuclear antigen antibodies (ENA) including anti-Ro and anti-La, anti-double stranded DNA
(anti-dsDNA), antiphospholipid antibodies (APLA), antineutrophilic cytoplasmic antibodies (ANCA), rheumatoid factor (RF), anti-cyclic citrullinated peptide (antiCCP), complement levels (C3, C4) were negative or
within normal range.
The neonate was transferred to a tertiary care neonatal
intensive care unit (NICU) on day 3 of life and had a
negative full septic work up including blood, urine and
cerebrospinal fluid cultures. Despite treatment with antibiotics (Vancomycin and Cefotaxime), fresh frozen
plasma (received every 12 h for 7 days) and topical nitroglycerin, the discoloration remained, particularly in the
left hand (Fig. 1). Stress dosing of hydrocortisone for
possible adrenal insufficiency (no cortisol level performed) was given due to the long in-utero exposure to
steroids in the mother. Heparin was given for potential
inherited thrombophilia and transitioned to Enoxaparin.
On day 11 of life, he was noted to have erythema of his
hands and feet, which prompted initial consideration for
neonatal Kawasaki disease (no other clinical criteria for

Fig. 1 Left hand on fifth day of life
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Kawasaki disease and he was afebrile at the time of first
intravenous immunoglobulin (IVIG) administration).
After two doses of IVIG (2 g/kg) short lived improvement was noted. Electrocardiogram (ECG) was normal
with no signs of dysrhythmia. An echocardiogram
showed enlarged coronary arteries (maximum in left anterior descending artery (LAD), z-score 3.93) with normal anatomy and systolic function. Two days after the
second dose of IVIG, fever returned (up to 38.2 degrees
Celsius), he had tachycardia, elevated CRP (maximum
CRP of 172 mg/L, normal < 3 mg/L) and oral prednisolone (2 mg/kg divided twice daily) was initiated. Inflammatory markers, skin discoloration and tachycardia
improved with steroid treatment. Repeat echocardiogram 1 week after starting prednisolone demonstrated
normal coronaries.
Full body magnetic resonance angiography (MRA) was
significant for abnormalities in the upper limbs with tortuosity and gadolinium enhancement of the brachial as
well as the distal axillary arteries. In the lower limbs, tortuosities and gadolinium enhancement involving distal
femoral, popliteal, posterior and anterior tibialis arteries
suggestive of vasculitis or vasculopathy (Fig. 2). Aortic,
pulmonary, renal and celiac trunk vessels were normal.
Given the clinical syndrome, imaging findings and response to corticosteroid administration, vasculitis was
favored.
The neonate’s autoimmune work included a negative
ANA, ENA (including anti-Ro/La), APLA, ANCA, RF,
and anti-smooth muscle antibody (ASMA). Complement
levels (C3, C4, CH50) and immunoglobulins (IgG, IgA,
IgM) were normal. Thrombophilia workup including
INR, PTT, fibrinogen, D-dimer, protein C, protein S, antithrombin, homocysteine level, Factor VIII level, lupus
anticoagulant, prothrombin mutation were within normal limits or negative. Work up for neonatal lupus erythematosus showed a normal ECG and echocardiogram
with no signs of cardiomyopathy or endocardial fibroelastosis. Ophthalmology exam was normal, with no signs
of retinal vasculitis. Newborn screen (Additional file 1)
was negative and his metabolic work up including ammonia level, plasma amino acids, urine organic acids,
total and free carnitine, acylcarnitine profile, methylmalonic acid level were normal. His DNA was screened
with targeted sequencing for known hereditary autoinflammatory diseases (17 next-generation sequencing
panel including Deficiency of Adenosine Deaminase 2
(DADA2) and STING-associated vasculopathy with infantile onset (SAVI)), however, we were not able to identify a causative mutation. Whole exome sequencing was
conducted as a trio (both Caucasian parents and the affected child were sequenced simultaneously), which did
not identify a pathogenic variant.
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Fig. 2 Magnetic resonance angiography at one month of age.
Gadolinium enhancing irregular and tortuous appearing medium
sized arteries bilaterally in the upper and lower extremities

Oral prednisolone was continued with improvement of
the discoloration in the infant’s hands and feet, however
the left index finger discoloration persisted with progression to necrosis. A diagnostic biopsy was considered but
was deferred due to the necrosis and likely low diagnostic yield. Enoxaparin was discontinued at 3 months of
age. The male infant was effectively weaned off steroids
by 5 months of age, he is now 4 years old with normal
growth and development. A follow up image of the hand
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at 21 months old is shown in Fig. 3. Repeat MRA at 17
months of age showed residual mild tortuosity of the
upper extremity abnormalities with no gadolinium enhancement and the lower limbs arteries normal in appearance with normalization of prior tortuosities (Fig. 4).
The mother was seen by an adult rheumatologist postpartum and repeat autoantibody profile remained negative (ANA, RF and anti-CCP). She was weaned off prednisone with a slow taper of approximately 3 months and
was treated with hydroxychloroquine for a total of 8
months. She remains in remission off therapy and has
had no further pregnancies.

Discussion
Vasculitides are rarely seen in neonates, with the exception of reported vasculitis occurring in infants of
mothers affected by systemic lupus erythematosus, Sjögren’s syndrome, and systemic vasculitides including Behçet’s disease, polyarteritis nodosa as well as microscopic
polyangiitis (MPA).
Stone et al. describes a pregnant 24-year-old Caucasian
woman with a history of cutaneous polyarteritis nodosa
(PAN) who had a flare during pregnancy and treated
with prednisone [3]. The newborn infant born at 36
weeks gestation had a “dusky” episode on day 1 of life,
then developed cyanosis of her left finger, left ear, nose,
upper lip and several toes. She had prominent livedo
reticularis on the proximal extremities and abdomen
with development of dermal nodules on the trunk, extremities as well as the scalp. She was started on heparin
and prednisone with improvement. Similar to our case,
cyanosis improved but the infant suffered from autoamputation of parts of three toe digits. A skin nodule
biopsy showed results consistent with medium sized

Fig. 4 Follow-up magnetic resonance angiography at 17 months of
age demonstrates residual tortuosity of forearm vessels with
normalization of lower extremity abnormalities and no
gadolinium enhancement

Fig. 3 Left hand at 21 months of age

vasculitis suggestive of polyarteritis nodosum [3]. Both
mother and baby were ANA, RF and ANCA negative.
The authors propose the presentation was caused by a
maternal factor crossing the placenta. In addition, the
neonate was found to have high levels of fibrinogen,
however low functioning, which could be secondary to
an abnormal fibrinogen molecule or antibody interfering
with functioning which could lead to a thrombophilia.
The neonate we present had fibrinogen levels within
normal range (2.86–3.37 g/L).
The mother, in our case, presented at 8 weeks gestational age with polyarthritis requiring high dose steroids.
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Angiogenesis and vasculogenesis begins at approximately
week 3 of pregnancy. Blood vessels continue to form in
the embryo and placenta until approximately 10 weeks,
when most organs are completely formed [4]. Our patient was extensively investigated for infectious, thrombophilia and genetic etiologies for a vasculitis syndrome
which were negative. Given his prematurity, there is further reduction in function of the Vitamin K dependent
coagulation factors and contact factors making thrombosis causing finger necrosis very unlikely [5, 6].
Bansal et al. described a case of a 32-year-old woman
with a history of polyarteritis nodosa (PAN), antimyeloperoxidase (MPO) positive and delivery of a premature female, by emergency caesarean section for preeclampsia [7]. The newborn developed pulmonary
hemorrhage requiring ventilatory support in addition to
proteinuria and hematuria. Treatment included hydrocortisone (3 mg/kg) and plasma exchange which led to
improvement. Umbilical cord blood showed elevated
anti-MPO antibody at 3.30 U/mL (reference range 0.00–
0.89 U/mL) which normalized with therapy. Hydrocortisone was successfully tapered over 3 weeks. This case
presenting with a mother with a known history of PAN
causing a transient vasculitis syndrome in her newborn
presumed related to placentally transferred autoantibody. Silva et al. described a 41-year-old woman with a
history of MPA, anti-MPO and anti-glomerular basement membrane positive who delivered a healthy term
baby boy [8]. Her disease remained in remission during
pregnancy with continued maintenance immunosuppression including low dose prednisone (7.5 mg/day) and
azathioprine (125 mg/day). Despite high levels of antiMPO (greater than 100 U/mL) measured in the newborn
immediately after birth, he did not develop any signs of
vasculitis. This suggests that the presence of anti-MPO
antibody positivity alone is not pathogenic and may require other factors or an inflammatory stimulus [8]. The
rarity of systemic vasculitis in neonates from known vasculitis in their mothers may then be explained by a combination of factors as well as disease control during
pregnancy.
During pregnancy, the hormonal profile causes immunomodulatory changes, with a shift from a Th1 to a Th2
lymphocyte predominant response [1]. Newer research has
suggested it may be a combination of other T cells and inflammatory markers including Th17, T regulatory cells,
tumor necrosis factor as well as IL-2 allowing tolerance of
the fetus that allows this [9]. Typically, rheumatoid arthritis
improves in pregnancy (Th1 predominant disease) while certain diseases such as systemic lupus erythematosus (Th2 predominant disease) tend to flare [2]. The presence of IgG
isotype autoantibodies in maternal diseases can cross the placenta causing antibody-mediated damage in the neonate
[10]. This includes neonatal lupus erythematosus (NLE) seen
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in mothers with anti-Ro/anti-La antibodies passing through
the placenta, immune thrombocytopenic purpura and antiphospholipid syndrome. Clearance of these passively transferred maternal antibodies occurs by 6 months of age. In our
case, the timing of prednisolone wean was concurrent with
expected timing for clearance of a suspected maternal antibody or factor. At 5 months of age, steroids were successfully
discontinued with no return of symptoms.

Conclusion
This is a unique case of new onset seronegative presumed reactive arthritis in a mother with the rare development of a successfully treated medium vessel
vasculitis in an infant. The etiology for the infant’s
symptoms is unknown but may be secondary to a transplacental transfer of an unidentified autoantibody, protein, cytokine or a combination of these factors with an
inflammatory stimulus which may explain his presentation. This theory is supported with complete recovery
following treatment in the neonate by 6 months of age
which coincides with timing for clearance of maternal
factors.
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